Valuation check: CERS's profit margin is -4.41%, below the Healthcare sector average of 15.52%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2026
Trailing 12 months ending Mar 2026
Cerus (CERS) currently reports a profit margin of -4.41% as of March 2026. That compares with -10.23% in the prior-year period — up 56.9% year over year. That is below the Healthcare sector average of 15.52%. Use the charts on this page to explore Cerus's profit margin history and peer comparisons.
Cerus's profit margin increased from -10.23% to -4.41% — a 56.9% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Cerus's profit margin of -4.41% is lower than the Healthcare sector average of 15.52%. That is roughly 128.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Cerus's current -4.41% should be judged against Healthcare norms (sector average: 15.52%) and against CERS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -4.41%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.52%. From there, open related valuation or income-statement pages for Cerus, and consider following CERS for alerts when major investors trade the stock.